Efficacy and Safety of Sirolimus in Active Systemic Lupus Erythematosus

NCT04582136 · clinicaltrials.gov ↗

PHASE3

Phase

ACTIVE_NOT_RECRUITING

Status

146

Enrollment

OTHER

Sponsor class

Conditions

Systemic Lupus Erythematosus

Interventions

DRUG: Sirolimus
DRUG: Placebo

Sponsor

Chinese SLE Treatment And Research Group

Collaborators

[object Object]
[object Object]